Explains the problems with allowing health insurance companies to sell plans in states where they are not licensed, including insurers evading and undermining consumer protections.
Explores how the Affordable Care Act expands the practice of offering immediate, temporary Medicaid coverage to people who appear to be eligible based on income.
Consumers, employers, and policymakers all need greater transparency in health care pricing. Learn what federal and state policymakers can do to improve access to health care price information.
Explains value-based insurance design and high-value care, outlines the key elements that value-based insurance should include.
Lays out the key elements consumer-friendly wellness programs should have and the ways advocates can help protect enrollees if their state proposes a program that jeopardizes enrollees’ access to care.
Highlights the limitations in states' abilities to keep health insurance premium increases in check and explains how health reform will give states more authority to do so.
Although the Affordable Care Act now offers individuals greatly expanded access to health coverage, simply having an insurance card does not guarantee access to high-quality health care.
In state houses all across the country, advocates, legislators, and state officials are considering proposals to restore the Affordable Care Act’s (ACA’s) temporary reinsurance program, which ended after 2016. This “Reinsurance 101” issue brief describes reinsurance and explains why it was originally included in the ACA. It then analyzes why some advocates and policymakers might consider implementing reinsurance in their states but others could hesitate to pursue such a policy.
Lowering the price of prescription drugs remains one of the top health care priorities for consumers.1 But pharmaceutical manufacturers continue to increase prices on lifesaving medications.2 A recent proposal from the Trump Administration seeks to control prescription drug costs in Medicaid by giving states the authority to eliminate people’s access to needed and even lifesaving drugs. This approach fails to address the underlying issue of pharmaceutical manufacturers setting such high prices at the national level.
Learn how patients and health care providers can team up to ensure better health care for consumers at a lower cost and in a timely manner.